ASTROTECH Corp Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments
ASTROTECH Corp (ASTC) reported Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments of $0 for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-08.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2020-09-08
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2020-06-30 was $0.00.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2020-03-31 was $0.00.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2019-12-31 was $0.00.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2019-09-30 was $0.00.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2020 was $0.00.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2019 was -$31.00K.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2018 was -$124.00K.
- ASTROTECH Corp available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2017 was -$60.00K.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 3 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 6 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 9 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-08 | $0.00 derived: sum of 2 quarters · filed 2020-09-08 | $0.00 derived: sum of 3 quarters · filed 2020-09-08 | $0.00 10-K · filed 2020-09-08 |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 4 quarters · filed 2020-09-08 |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 | $0.00 derived: sum of 3 quarters · filed 2020-09-08 | $0.00 derived: sum of 4 quarters · filed 2020-09-08 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2020-09-08 | $0.00 derived: sum of 3 quarters · filed 2020-09-08 | $0.00 derived: sum of 4 quarters · filed 2020-09-08 |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-08 | $0.00 derived: sum of 2 quarters · filed 2020-09-08 | $0.00 derived: sum of 3 quarters · filed 2020-09-08 | -$31.00K 10-K · filed 2020-09-08 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | -$31.00K 10-Q · filed 2020-05-14 | -$79.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$31.00K 10-Q · filed 2020-02-14 | -$79.00K derived: sum of 3 quarters · filed 2020-02-14 | -$121.00K derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | -$31.00K 10-Q · filed 2019-11-14 | -$79.00K derived: sum of 2 quarters · filed 2019-11-14 | -$121.00K derived: sum of 3 quarters · filed 2019-11-14 | -$154.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | -$90.00K derived: sum of 2 quarters · filed 2019-09-30 | -$123.00K derived: sum of 3 quarters · filed 2019-09-30 | -$124.00K 10-K · filed 2019-09-30 |
| 2018-03-31 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13 | -$75.00K derived: sum of 2 quarters · filed 2019-05-13 | -$76.00K 10-Q · filed 2019-05-13 | -$76.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | -$34.00K 10-Q · filed 2019-02-12 | -$34.00K derived: sum of 3 quarters · filed 2019-02-12 | -$34.00K derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-09-30 | -$1.00K 10-Q · filed 2018-11-14 | -$1.00K derived: sum of 2 quarters · filed 2018-11-14 | -$1.00K derived: sum of 3 quarters · filed 2018-11-14 | -$61.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-25 | $0.00 derived: sum of 2 quarters · filed 2018-09-25 | -$60.00K derived: sum of 3 quarters · filed 2018-09-25 | -$60.00K 10-K · filed 2018-09-25 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | -$60.00K derived: sum of 2 quarters · filed 2018-05-15 | -$60.00K 10-Q · filed 2018-05-15 | -$68.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$60.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-02-12 | -$60.00K 10-Q · filed 2018-02-12 | -$68.00K derived: sum of 3 quarters · filed 2018-02-12 | -$60.00K derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-09-30 | $0.00 10-Q/A · filed 2018-02-12 | -$8.00K derived: sum of 2 quarters · filed 2018-02-12 | $0.00 derived: sum of 3 quarters · filed 2018-02-12 | |
| 2016-06-30 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18 | $0.00 derived: sum of 2 quarters · filed 2017-09-18 | -$14.00K 10-K · filed 2017-09-18 | |
| 2016-03-31 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | -$6.00K 10-Q · filed 2017-05-09 | ||
| 2015-12-31 | -$14.00K 10-Q · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |